CEPU on NYSE
CENTRAL PUERTO S.A.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Edenor S.A., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in ARS, the currency the company reports in.
Key numbers, fiscal 2024
39.5%Gross margin3
26.7%Operating margin3
8.3%Net margin3
8.1%Revenue growth, 20243
3.3%Return on equity3
115.7B ARSFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Sales Under Contract brought in 82% of the revenue CENTRAL PUERTO S.A. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Sales Under Contract | 375.3B ARS | 392.8B ARS | 450.3B ARS |
| Steam sales | 42.4B ARS | 52.0B ARS | 51.8B ARS |
| Revenues From Forest Activity | 16.7B ARS | 28.7B ARS | 19.1B ARS |
| Revenues From CVO Thermal Plant Management | 13.1B ARS | 20.1B ARS | 18.6B ARS |
| Resale Of Gas Transport And Distribution Capacity | 5.3B ARS | 8.0B ARS | 8.9B ARS |
Business segments
Electric Power Generation Conventional brought in 55% of the revenue CENTRAL PUERTO S.A. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Electric Power Generation Conventional | 705.0B ARS | 751.2B ARS | 877.9B ARS |
| Natural Gas Distribution | 424.4B ARS | 654.6B ARS | 499.5B ARS |
| Electric Power Generation Renewable | 158.2B ARS | 162.9B ARS | 169.3B ARS |
| Others | 13.1B ARS | 20.1B ARS | 24.5B ARS |
| Forest Activity | 16.7B ARS | 28.7B ARS | 19.1B ARS |
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Other costs92¢676.9B ARS
- Profit8¢61.3B ARS
Out of 738.2B ARS in revenue.3
Where each dollar of operating cash went, fiscal 2024
- Capital spending55¢142.5B ARS
- Kept or used elsewhere45¢115.7B ARS
Out of 258.2B ARS of cash from operations.3
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenues | 1.1T ARS | 971.1B ARS | 898.3B ARS |
| Cost of sales | -704.5B ARS | -587.4B ARS | -602.1B ARS |
| Gross income | 392.9B ARS | 383.7B ARS | 296.2B ARS |
| Administrative and selling expenses | -101.4B ARS | -101.1B ARS | -91.0B ARS |
| Other operating income | 129.7B ARS | 165.3B ARS | 680.9B ARS |
| Other operating expenses | -111.8B ARS | -54.2B ARS | -43.3B ARS |
| Impairment Reversal (Impairment) of property, plant and equipment and intangible assets | 61.0B ARS | -134.3B ARS | 126.0B ARS |
| Operating income | 370.4B ARS | 259.4B ARS | 968.9B ARS |
| Gain (Loss) on net monetary position | 6.4B ARS | -24.8B ARS | -362.4B ARS |
| Finance income | 125.5B ARS | 154.3B ARS | 659.5B ARS |
| Finance expenses | -243.6B ARS | -225.8B ARS | -1.0T ARS |
| Share of the profit of associates | 59.7B ARS | 21.2B ARS | 17.5B ARS |
| Result from investments in entities measured at fair value | 134.6B ARS | 3.3B ARS | |
| Gain from bargain purchase | 208.1B ARS | ||
| Income before income tax | 453.0B ARS | 187.7B ARS | 469.5B ARS |
| Income tax for the year | -100.2B ARS | -107.2B ARS | -51.4B ARS |
| Net income for the year | 352.8B ARS | 80.6B ARS | 418.1B ARS |
| Equity holders of the parent | 346.4B ARS | 65.2B ARS | 424.1B ARS |
| Non-controlling interests | 6.5B ARS | 15.3B ARS | -6.0B ARS |
| Total net income loss for the year | 352.8B ARS | 80.6B ARS | 418.1B ARS |
| Basic earnings per share | 230.61 ARS | 43.42 ARS | 282.24 ARS |
| Diluted earnings per share | 230.61 ARS | 43.42 ARS | 282.24 ARS |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Property, plant and equipment | 2.3T ARS | 2.1T ARS | |
| Intangible assets | 40.5B ARS | 40.4B ARS | |
| Biological assets | 191.6B ARS | 245.7B ARS | |
| Investments in associates | 28.6B ARS | 143.7B ARS | |
| Inventories | 12.6B ARS | 5.6B ARS | |
| Other non-financial assets | 11.5B ARS | 904.0M ARS | |
| Trade and other receivables | 128.2B ARS | 179.9B ARS | |
| Other financial assets | 184.6B ARS | 19.7B ARS | |
| Deferred tax asset | 4.2B ARS | 8.4B ARS | |
| Total non current assets | 2.9T ARS | 2.8T ARS | |
| Biological assets | 13.3B ARS | 46.2B ARS | |
| Inventories | 28.3B ARS | 28.7B ARS | |
| Other non-financial assets | 22.5B ARS | 46.9B ARS | |
| Trade and other receivables | 320.4B ARS | 286.4B ARS | |
| Other financial assets | 300.2B ARS | 315.9B ARS | |
| Cash and cash equivalents | 37.7B ARS | 5.1B ARS | |
| Total current assets | 722.4B ARS | 729.2B ARS | |
| Total assets | 3.7T ARS | 3.5T ARS | |
| Capital stock | 1.5B ARS | 1.5B ARS | |
| Adjustment to capital stock | 559.6B ARS | 704.8B ARS | |
| Treasury shares | 13.9M ARS | 11.4M ARS | |
| Adjustment to treasury shares | 4.2B ARS | 5.3B ARS | |
| Cost of treasury shares | -8.5B ARS | -5.0B ARS | |
| Legal reserve | 142.3B ARS | 139.4B ARS | |
| Voluntary reserve | 992.0B ARS | 992.0B ARS | |
| Other equity accounts | -48.0B ARS | -48.8B ARS | |
| Voluntary reserve for future dividends distribution | 575.6B ARS | 511.6B ARS | |
| Retained earnings | 332.5B ARS | 67.0B ARS | |
| Equity attributable to holders of the parent | 2.6T ARS | 2.4T ARS | |
| Non-controlling interests | 64.8B ARS | 82.9B ARS | |
| Total equity | 2.6T ARS | 2.5T ARS | 2.5T ARS |
| Trade and other payables | 887.8M ARS | ||
| Other non-financial liabilities | 21.7B ARS | 32.6B ARS | |
| Loans and borrowings | 348.9B ARS | 302.6B ARS | |
| Compensation and employee benefits liabilities | 9.7B ARS | 10.1B ARS | |
| Provisions | 9.5B ARS | 3.0B ARS | |
| Income tax payable Payment plan | 8.9B ARS | ||
| Deferred income tax liabilities | 247.4B ARS | 209.0B ARS | |
| Total non current liabilities | 646.2B ARS | 558.1B ARS | |
| Trade and other payables | 124.2B ARS | 126.1B ARS | |
| Other non-financial liabilities | 55.9B ARS | 40.3B ARS | |
| Loans and borrowings | 144.1B ARS | 198.3B ARS | |
| Compensation and employee benefits liabilities | 43.6B ARS | 44.6B ARS | |
| Income tax payable | 35.8B ARS | 79.8B ARS | |
| Provisions | 3.9B ARS | 3.9B ARS | |
| Total current liabilities | 407.5B ARS | 492.9B ARS | |
| Total liabilities | 1.1T ARS | 1.1T ARS | |
| Total equity and liabilities | 3.7T ARS | 3.5T ARS |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Income for the year before income tax: | 453.0B ARS | 187.7B ARS | 469.5B ARS |
| Depreciation of property, plant and equipment | 160.7B ARS | 146.1B ARS | 183.5B ARS |
| Amortization of intangible assets | 2.3B ARS | 3.5B ARS | 17.6B ARS |
| (Impairment Reversal) Impairment of property, plant and equipment and intangible assets | -61.0B ARS | 134.3B ARS | -126.0B ARS |
| Loss on disposal of property, plant and equipment | 16.0B ARS | 24.2B ARS | |
| (Charge) recovery for discount of tax credits | -471.6M ARS | 127.0M ARS | 2.2B ARS |
| Interest earned from customers | -24.0B ARS | -41.0B ARS | -90.5B ARS |
| Finance income | -125.5B ARS | -154.3B ARS | -659.5B ARS |
| Finance expenses | 243.6B ARS | 225.8B ARS | 1.0T ARS |
| Insurance recovery | -18.9B ARS | -12.6B ARS | |
| Share of the profit of associates | -59.7B ARS | -21.2B ARS | -17.5B ARS |
| Gain from bargain purchase | -208.1B ARS | ||
| Result from investment in entities mesuared at fair value | -134.6B ARS | -3.3B ARS | |
| Material and spare parts impairment | 930.6M ARS | 1.8B ARS | 2.1B ARS |
| Movements in provisions and long-term employee benefit plan expense | 6.0B ARS | 15.7B ARS | 10.6B ARS |
| Biological assets revaluation | 87.0B ARS | -28.6B ARS | -36.3B ARS |
| Foreign exchange difference for trade receivables | -73.1B ARS | -76.8B ARS | -546.2B ARS |
| Net effect CAMMESA agreement - Resolution SE No 58/2024 and 66/2024 | 16.2B ARS | ||
| Results on net monetary position | -60.3B ARS | -55.1B ARS | 348.6B ARS |
| Decrease in trade and other receivables | 15.5B ARS | 80.8B ARS | 123.1B ARS |
| Decrease (Increase) in other non-financial assets, inventories and biological assets | 541.9M ARS | 1.1B ARS | -88.0B ARS |
| Decrease in trade and other payables, other non-financial liabilities and liabilities from employee benefits | -21.8B ARS | -117.0B ARS | -54.8B ARS |
| Interest received from customers | 21.5B ARS | 48.4B ARS | 84.0B ARS |
| Income tax paid | -21.3B ARS | -19.5B ARS | -98.4B ARS |
| Tax interest paid | -957.7M ARS | -1.1B ARS | -2.7B ARS |
| Insurance recovery collected | 5.7B ARS | 8.6B ARS | 338.0M ARS |
| Net cash flows provided by operating activities | 411.2B ARS | 339.7B ARS | 359.8B ARS |
| Purchase of property, plant and equipment and materials | -295.4B ARS | -187.5B ARS | -28.2B ARS |
| Dividends collected | 26.8B ARS | 10.7B ARS | 19.3B ARS |
| Sale of property, plant and equipment | 1.5B ARS | ||
| Acquisition of associates | -7.7B ARS | -103.2B ARS | |
| Acquisition of other financial assets, net | -133.3M ARS | -41.7B ARS | -70.0B ARS |
| Net cash flows used in investing activities | -276.4B ARS | -216.9B ARS | -182.1B ARS |
| Bank and investment accounts overdrafts received | 18.3B ARS | 28.6B ARS | 5.0B ARS |
| Bank and investment accounts overdrafts paid | -28.6B ARS | -5.0B ARS | -18.8B ARS |
| Loans and other financial debts received | 183.8B ARS | 85.0B ARS | 206.0B ARS |
| Loans and other financial debts paid | -233.2B ARS | -172.1B ARS | -266.7B ARS |
| Corporate bonds repurchase payment | -18.5B ARS | ||
| Direct financing and loans refinancing costs paid | -33.5B ARS | -52.6B ARS | -72.0B ARS |
| Interest and other financial costs paid | -4.9B ARS | ||
| Bank fees and expenses paid | -2.0B ARS | -1.5B ARS | -635.4M ARS |
| Dividends paid | -1.0B ARS | -21.9B ARS | -62.8B ARS |
| Contribution of non-controlling interests | 10.1M ARS | ||
| Net cash flows used in financing activities | -96.2B ARS | -144.4B ARS | -228.5B ARS |
| Increase (Decrease) in cash and cash equivalents | 38.5B ARS | -21.7B ARS | -50.8B ARS |
| Exchange difference and other financial results | -112.7M ARS | 1.3B ARS | 58.5B ARS |
| RECPAM generated by cash and cash equivalents | -5.8B ARS | -13.2B ARS | -51.6B ARS |
| Acquisition of PP&E pending payment and through pre-financing | 19.2B ARS | 62.0B ARS | 34.8B ARS |
| Incorporation of PP&E, financial assets, and financial debts through the acquisition of companies | 563.7B ARS | ||
| Agreement with CAMMESA - Resolutions SE N 58/2024 and 66/2024 (Note 1.2.p) | 59.2B ARS | ||
| Acquisition of financial assets through the TRUST | 32.8B ARS | 27.4B ARS | 44.8B ARS |
| Acquisition of investment in associate | 15.5B ARS | 27.7B ARS | |
| Payment of dividends through securities | 71.6B ARS | 281.6B ARS | |
| Cancellation of financial debts through the TRUST - Capital | 6.7B ARS | 6.5B ARS | 5.6B ARS |
| Cancellation of financial debts through the TRUST - Interest | 7.5B ARS | 8.7B ARS | 8.4B ARS |
| Disbursements received through pre-financing | 17.8B ARS | ||
| Fees to secure financing | 8.3B ARS | ||
| Spin-off of the ECOGAS Group | 145.9B ARS | ||
| Redemption of minority shareholders shares (See Note 18) | 36.2B ARS |
Recent filings
- Oct 14, 20266-K
- Oct 14, 20266-K
- Oct 14, 20266-K
- Oct 13, 20266-K
- Oct 9, 20266-K
- Oct 8, 20266-K
- Oct 7, 20266-K
- Oct 5, 20266-K
- Oct 2, 20266-K
- Oct 1, 20266-K
- Sep 30, 20266-K
- Sep 29, 20266-K
- Sep 25, 20266-K
- Sep 24, 20266-K
- Sep 16, 20266-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9